The Use of Human Liver Cell Model and Cytochrome P450 Substrate—Inhibitor Panel for Studies of Dasatinib and Warfarin Interactions
Crossref DOI link: https://doi.org/10.1007/s10517-017-3651-z
Published Online: 2017-02-27
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zakharyants, A. A.
Burmistrova, O. A.
Poloznikov, A. A.
License valid from 2017-02-01